WVU010220: Phase I/II Study of Neoadjuvant FOLFIRINOX in Combination with Peri-Operative Oral Hydroxychloroquine (FHQ) in Subjects with Resectable Adenocarcinoma of the Pancreas
- Title
- Phase I/II Study of Neoadjuvant FOLFIRINOX in Combination with Peri-Operative Oral Hydroxychloroquine (FHQ) in Subjects with Resectable Adenocarcinoma of the Pancreas
- Principal Investigator
- Boone, Brian
- Phase
- I/II
- Age Group
- Adult
- Applicable Disease Sites
- Gastrointestinal Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Erin Brody, BA
- Clinical Research Coordinator
- Email: Erin.Brody@hsc.wvu.edu